{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:03:28Z","timestamp":1791864208607,"version":"4.3.4"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["24010902153"],"award-info":[{"award-number":["24010902153"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09045-2","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:30:46Z","timestamp":1745227846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma"],"prefix":"10.1007","volume":"68","author":[{"given":"Lina","family":"Sahnoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuloud","family":"Bajbouj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Mahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qutayba","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"1","key":"9045_CR1","doi-asserted-by":"publisher","first-page":"2269653","DOI":"10.1080\/20018525.2023.2269653","volume":"10","author":"J Pakkasela","year":"2023","unstructured":"Pakkasela J et al (2023) Age at asthma diagnosis and onset of symptoms among adults with allergic and non-allergic asthma. Eur Clin Respir J 10(1):2269653. https:\/\/doi.org\/10.1080\/20018525.2023.2269653","journal-title":"Eur Clin Respir J"},{"issue":"6","key":"9045_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2500\/aap.2019.40.4253","volume":"40","author":"N Padem","year":"2019","unstructured":"Padem N, Saltoun C (2019) Classification of asthma. Allergy Asthma Proc 40(6):385\u2013388. https:\/\/doi.org\/10.2500\/aap.2019.40.4253","journal-title":"Allergy Asthma Proc"},{"issue":"10258","key":"9045_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases GBD, Injuries C (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"key":"9045_CR4","doi-asserted-by":"publisher","unstructured":"Ricciardolo FLM, Bertolini F, Carriero V (2021) The Role of Dupilumab in Severe Asthma. Biomedicines 9(9). https:\/\/doi.org\/10.3390\/biomedicines9091096","DOI":"10.3390\/biomedicines9091096"},{"issue":"1","key":"9045_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","volume":"144","author":"R Kaur","year":"2019","unstructured":"Kaur R, Chupp G (2019) Phenotypes and endotypes of adult asthma: Moving toward precision medicine. J Allergy Clin Immunol 144(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jaci.2019.05.031","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9045_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P et al (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178(3):218\u2013224. https:\/\/doi.org\/10.1164\/rccm.200711-1754OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"9045_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE (2012) Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18(5):716\u2013725. https:\/\/doi.org\/10.1038\/nm.2678","journal-title":"Nat Med"},{"issue":"4","key":"9045_CR8","doi-asserted-by":"publisher","first-page":"CD012226","DOI":"10.1002\/14651858.CD012226.pub2","volume":"4","author":"R Normansell","year":"2017","unstructured":"Normansell R, Kew KM, Stovold E (2017) Interventions to improve adherence to inhaled steroids for asthma. Cochrane Database Syst Rev 4(4):CD012226. https:\/\/doi.org\/10.1002\/14651858.CD012226.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"9045_CR9","doi-asserted-by":"publisher","unstructured":"Volmer T et al (2018) Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J 52(4). https:\/\/doi.org\/10.1183\/13993003.00703-2018","DOI":"10.1183\/13993003.00703-2018"},{"issue":"3","key":"9045_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40259-024-00653-6","volume":"38","author":"PM Cutroneo","year":"2024","unstructured":"Cutroneo PM et al (2024) Safety of biological therapies for severe asthma: an analysis of suspected adverse reactions reported in the WHO pharmacovigilance database. BioDrugs 38(3):425\u2013448. https:\/\/doi.org\/10.1007\/s40259-024-00653-6","journal-title":"BioDrugs"},{"issue":"4","key":"9045_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","volume":"199","author":"MC McGregor","year":"2019","unstructured":"McGregor MC et al (2019) Role of biologics in asthma. Am J Respir Crit Care Med 199(4):433\u2013445. https:\/\/doi.org\/10.1164\/rccm.201810-1944CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"9045_CR12","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.cell.2021.04.019","volume":"184","author":"H Hammad","year":"2021","unstructured":"Hammad H, Lambrecht BN (2021) The basic immunology of asthma. Cell 184(9):2521\u20132522. https:\/\/doi.org\/10.1016\/j.cell.2021.04.019","journal-title":"Cell"},{"issue":"5","key":"9045_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan SP et al (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38(5):709\u2013750. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.02958.x","journal-title":"Clin Exp Allergy"},{"key":"9045_CR14","doi-asserted-by":"publisher","unstructured":"Nakagome K, Nagata M (2024) The possible roles of IL-4\/IL-13 in the development of eosinophil-predominant severe asthma. Biomolecules 14(5). https:\/\/doi.org\/10.3390\/biom14050546","DOI":"10.3390\/biom14050546"},{"key":"9045_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.10.025","author":"PA Alvarado-Vazquez","year":"2024","unstructured":"Alvarado-Vazquez PA et al (2024) Targeting of the IL-5 pathway in severe asthma reduces mast cell progenitors. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2024.10.025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9045_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cyto.2015.05.019","volume":"75","author":"JJ McLeod","year":"2015","unstructured":"McLeod JJ, Baker B, Ryan JJ (2015) Mast cell production and response to IL-4 and IL-13. Cytokine 75(1):57\u201361. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.019","journal-title":"Cytokine"},{"issue":"2","key":"9045_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jleuko\/qiad065","volume":"114","author":"T Salomaa","year":"2023","unstructured":"Salomaa T et al (2023) Low IL-13R\u03b11 expression on mast cells tunes them unresponsive to IL-13. J Leukoc Biol 114(2):187\u2013194. https:\/\/doi.org\/10.1093\/jleuko\/qiad065","journal-title":"J Leukoc Biol"},{"issue":"1","key":"9045_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/1744666X.2020.1860755","volume":"17","author":"M Andrea","year":"2021","unstructured":"Andrea M et al (2021) The emerging role of type 2 inflammation in asthma. Expert Rev Clin Immunol 17(1):63\u201371. https:\/\/doi.org\/10.1080\/1744666X.2020.1860755","journal-title":"Expert Rev Clin Immunol"},{"key":"9045_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fphar.2019.01387","volume":"10","author":"G Marone","year":"2019","unstructured":"Marone G et al (2019) The intriguing role of interleukin 13 in the pathophysiology of asthma. Front Pharmacol 10:1387. https:\/\/doi.org\/10.3389\/fphar.2019.01387","journal-title":"Front Pharmacol"},{"key":"9045_CR20","doi-asserted-by":"publisher","unstructured":"Pavlidis S et al (2019) \"T2-high\" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J 53(1). https:\/\/doi.org\/10.1183\/13993003.00938-2018","DOI":"10.1183\/13993003.00938-2018"},{"issue":"8","key":"9045_CR21","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1111\/all.14297","volume":"75","author":"KT Barretto","year":"2020","unstructured":"Barretto KT et al (2020) Human airway epithelial cells express a functional IL-5 receptor. Allergy 75(8):2127\u20132130. https:\/\/doi.org\/10.1111\/all.14297","journal-title":"Allergy"},{"issue":"3","key":"9045_CR22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/all.15627","volume":"78","author":"K Bajbouj","year":"2023","unstructured":"Bajbouj K et al (2023) IL-5 receptor expression in lung fibroblasts: Potential role in airway remodeling in asthma. Allergy 78(3):882\u2013885. https:\/\/doi.org\/10.1111\/all.15627","journal-title":"Allergy"},{"issue":"3","key":"9045_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaci.2011.04.047","volume":"128","author":"S Al-Muhsen","year":"2011","unstructured":"Al-Muhsen S, Johnson JR, Hamid Q (2011) Remodeling in asthma. J Allergy Clin Immunol 128(3):451\u201362. https:\/\/doi.org\/10.1016\/j.jaci.2011.04.047. (quiz 463-4)","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9045_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","volume":"113","author":"SG Johansson","year":"2004","unstructured":"Johansson SG et al (2004) Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 113(5):832\u2013836. https:\/\/doi.org\/10.1016\/j.jaci.2003.12.591","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"9045_CR25","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/s0167-5699(99)01535-2","volume":"20","author":"M Humbert","year":"1999","unstructured":"Humbert M et al (1999) The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 20(11):528\u2013533. https:\/\/doi.org\/10.1016\/s0167-5699(99)01535-2","journal-title":"Immunol Today"},{"issue":"1","key":"9045_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL et al (2006) Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11(1):54\u201361. https:\/\/doi.org\/10.1111\/j.1440-1843.2006.00784.x","journal-title":"Respirology"},{"issue":"2","key":"9045_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/all.13985","volume":"75","author":"E Sze","year":"2020","unstructured":"Sze E, Bhalla A, Nair P (2020) Mechanisms and therapeutic strategies for non-T2 asthma. Allergy 75(2):311\u2013325. https:\/\/doi.org\/10.1111\/all.13985","journal-title":"Allergy"},{"issue":"7","key":"9045_CR28","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","volume":"136","author":"TR Mosmann","year":"1986","unstructured":"Mosmann TR et al (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7):2348\u201357","journal-title":"J Immunol"},{"issue":"1","key":"9045_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaci.2010.10.024","volume":"127","author":"KJ Baines","year":"2011","unstructured":"Baines KJ et al (2011) Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. J Allergy Clin Immunol 127(1):153-160 e1-9. https:\/\/doi.org\/10.1016\/j.jaci.2010.10.024","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9045_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","volume":"180","author":"PG Woodruff","year":"2009","unstructured":"Woodruff PG et al (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 180(5):388\u2013395. https:\/\/doi.org\/10.1164\/rccm.200903-0392OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9045_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jaip.2019.11.020","volume":"8","author":"AM Coverstone","year":"2020","unstructured":"Coverstone AM, Seibold MA, Peters MC (2020) Diagnosis and management of T2-high asthma. J Allergy Clin Immunol Pract 8(2):442\u2013450. https:\/\/doi.org\/10.1016\/j.jaip.2019.11.020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"9045_CR32","doi-asserted-by":"publisher","unstructured":"Kyriakopoulos C et al (2021) Identification and treatment of T2-low asthma in the era of biologics. ERJ Open Res 7(2). https:\/\/doi.org\/10.1183\/23120541.00309-2020","DOI":"10.1183\/23120541.00309-2020"},{"issue":"2","key":"9045_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF et al (2014) International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43(2):343\u2013373. https:\/\/doi.org\/10.1183\/09031936.00202013","journal-title":"Eur Respir J"},{"issue":"2","key":"9045_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4168\/aair.2021.13.2.219","volume":"13","author":"G Senna","year":"2021","unstructured":"Senna G et al (2021) Sex differences in severe asthma: results from severe asthma network in Italy-SANI. Allergy Asthma Immunol Res 13(2):219\u2013228. https:\/\/doi.org\/10.4168\/aair.2021.13.2.219","journal-title":"Allergy Asthma Immunol Res"},{"key":"9045_CR35","doi-asserted-by":"publisher","unstructured":"Chowdhury NU et al (2021) Sex and gender in asthma. Eur Respir Rev 30(162). https:\/\/doi.org\/10.1183\/16000617.0067-2021","DOI":"10.1183\/16000617.0067-2021"},{"key":"9045_CR36","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.mam.2021.100969","volume":"85","author":"G Caramori","year":"2022","unstructured":"Caramori G et al (2022) Corticosteroid resistance in asthma: cellular and molecular mechanisms. Mol Aspects Med 85:100969. https:\/\/doi.org\/10.1016\/j.mam.2021.100969","journal-title":"Mol Aspects Med"},{"key":"9045_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/164_2016_98","volume":"237","author":"IM Adcock","year":"2017","unstructured":"Adcock IM, Mumby S (2017) Glucocorticoids. Handb Exp Pharmacol 237:171\u2013196. https:\/\/doi.org\/10.1007\/164_2016_98","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"9045_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1067\/mai.2002.122465","volume":"109","author":"E Irusen","year":"2002","unstructured":"Irusen E et al (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 109(4):649\u2013657. https:\/\/doi.org\/10.1067\/mai.2002.122465","journal-title":"J Allergy Clin Immunol"},{"key":"9045_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105189","volume":"160","author":"I Henderson","year":"2020","unstructured":"Henderson I et al (2020) Why do some asthma patients respond poorly to glucocorticoid therapy? Pharmacol Res 160:105189. https:\/\/doi.org\/10.1016\/j.phrs.2020.105189","journal-title":"Pharmacol Res"},{"issue":"23","key":"9045_CR40","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1128\/MCB.05866-11","volume":"31","author":"AJ Galliher-Beckley","year":"2011","unstructured":"Galliher-Beckley AJ, Williams JG, Cidlowski JA (2011) Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol Cell Biol 31(23):4663\u20134675. https:\/\/doi.org\/10.1128\/MCB.05866-11","journal-title":"Mol Cell Biol"},{"issue":"9596","key":"9045_CR41","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","volume":"370","author":"S Wenzel","year":"2007","unstructured":"Wenzel S et al (2007) Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370(9596):1422\u20131431. https:\/\/doi.org\/10.1016\/S0140-6736(07)61600-6","journal-title":"Lancet"},{"issue":"1 Pt 1","key":"9045_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1067\/mai.2000.107926","volume":"106","author":"AJ Sandford","year":"2000","unstructured":"Sandford AJ et al (2000) Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 106(1 Pt 1):135\u2013140. https:\/\/doi.org\/10.1067\/mai.2000.107926","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"9045_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10753-016-0503-3","volume":"40","author":"ML Alasandagutti","year":"2017","unstructured":"Alasandagutti ML et al (2017) Role of IL-13 genetic variants in signalling of asthma. Inflammation 40(2):566\u2013577. https:\/\/doi.org\/10.1007\/s10753-016-0503-3","journal-title":"Inflammation"},{"key":"9045_CR44","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.mam.2021.100995","volume":"85","author":"ZI Komlosi","year":"2022","unstructured":"Komlosi ZI et al (2022) Cellular and molecular mechanisms of allergic asthma. Mol Aspects Med 85:100995. https:\/\/doi.org\/10.1016\/j.mam.2021.100995","journal-title":"Mol Aspects Med"},{"key":"9045_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fmed.2020.00191","volume":"7","author":"KP Hough","year":"2020","unstructured":"Hough KP et al (2020) Airway remodeling in asthma. Front Med (Lausanne) 7:191. https:\/\/doi.org\/10.3389\/fmed.2020.00191","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"9045_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41374-020-0404-9","volume":"100","author":"X Hu","year":"2020","unstructured":"Hu X et al (2020) PI3K-Akt-mTOR\/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest 100(6):801\u2013811. https:\/\/doi.org\/10.1038\/s41374-020-0404-9","journal-title":"Lab Invest"},{"issue":"5","key":"9045_CR47","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jaci.2008.02.017","volume":"121","author":"AM Slats","year":"2008","unstructured":"Slats AM et al (2008) Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma. J Allergy Clin Immunol 121(5):1196\u20131202. https:\/\/doi.org\/10.1016\/j.jaci.2008.02.017","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"9045_CR48","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/jcm8091451","volume":"8","author":"FT Chung","year":"2019","unstructured":"Chung FT et al (2019) Increased ratio of matrix metalloproteinase-9 (MMP-9)\/tissue inhibitor metalloproteinase-1 from alveolar macrophages in chronic asthma with a fast decline in FEV1 at 5-year follow-up. J Clin Med 8(9):1451. https:\/\/doi.org\/10.3390\/jcm8091451","journal-title":"J Clin Med"},{"issue":"6","key":"9045_CR49","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1164\/ajrccm.158.6.9803014","volume":"158","author":"AM Vignola","year":"1998","unstructured":"Vignola AM et al (1998) Sputum metalloproteinase-9\/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 158(6):1945\u20131950. https:\/\/doi.org\/10.1164\/ajrccm.158.6.9803014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"9045_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cyto.2015.05.014","volume":"75","author":"N Gour","year":"2015","unstructured":"Gour N, Wills-Karp M (2015) IL-4 and IL-13 signaling in allergic airway disease. Cytokine 75(1):68\u201378. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.014","journal-title":"Cytokine"},{"issue":"9","key":"9045_CR51","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/eji.201948161","volume":"49","author":"C Symowski","year":"2019","unstructured":"Symowski C, Voehringer D (2019) Th2 cell-derived IL-4\/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Eur J Immunol 49(9):1421\u20131432. https:\/\/doi.org\/10.1002\/eji.201948161","journal-title":"Eur J Immunol"},{"issue":"5","key":"9045_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1101\/gr.7.5.495","volume":"7","author":"KA Frazer","year":"1997","unstructured":"Frazer KA et al (1997) Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res 7(5):495\u2013512. https:\/\/doi.org\/10.1101\/gr.7.5.495","journal-title":"Genome Res"},{"issue":"9","key":"9045_CR53","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1002\/eji.201142227","volume":"42","author":"E Gallo","year":"2012","unstructured":"Gallo E, Katzman S, Villarino AV (2012) IL-13-producing Th1 and Th17 cells characterize adaptive responses to both self and foreign antigens. Eur J Immunol 42(9):2322\u20132328. https:\/\/doi.org\/10.1002\/eji.201142227","journal-title":"Eur J Immunol"},{"issue":"2","key":"9045_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1165\/rcmb.2007-0173OC","volume":"38","author":"S Allahverdian","year":"2008","unstructured":"Allahverdian S et al (2008) Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. Am J Respir Cell Mol Biol 38(2):153\u2013160. https:\/\/doi.org\/10.1165\/rcmb.2007-0173OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9045_CR55","doi-asserted-by":"publisher","first-page":"851940","DOI":"10.3389\/fphar.2022.851940","volume":"13","author":"C Pelaia","year":"2022","unstructured":"Pelaia C et al (2022) Interleukins 4 and 13 in asthma: key pathophysiologic cytokines and druggable molecular targets. Front Pharmacol 13:851940. https:\/\/doi.org\/10.3389\/fphar.2022.851940","journal-title":"Front Pharmacol"},{"key":"9045_CR56","doi-asserted-by":"publisher","first-page":"153392","DOI":"10.1016\/j.phymed.2020.153392","volume":"80","author":"SJ Park","year":"2021","unstructured":"Park SJ et al (2021) Tilianin attenuates HDM-induced allergic asthma by suppressing Th2-immune responses via downregulation of IRF4 in dendritic cells. Phytomedicine 80:153392. https:\/\/doi.org\/10.1016\/j.phymed.2020.153392","journal-title":"Phytomedicine"},{"issue":"5","key":"9045_CR57","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jaci.2005.07.029","volume":"116","author":"C Bergeron","year":"2005","unstructured":"Bergeron C et al (2005) Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. J Allergy Clin Immunol 116(5):983\u2013989. https:\/\/doi.org\/10.1016\/j.jaci.2005.07.029","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9045_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12890-019-0789-7","volume":"19","author":"J Sha","year":"2019","unstructured":"Sha J, Rorke S, Langton D (2019) Airway smooth muscle as an underutilised biomarker: a case report. BMC Pulm Med 19(1):24. https:\/\/doi.org\/10.1186\/s12890-019-0789-7","journal-title":"BMC Pulm Med"},{"issue":"11","key":"9045_CR59","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/j.1365-2222.2005.02360.x","volume":"35","author":"A Chetta","year":"2005","unstructured":"Chetta A et al (2005) Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy 35(11):1437\u20131442. https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02360.x","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"9045_CR60","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jaci.2016.07.037","volume":"139","author":"R Al-Kufaidy","year":"2017","unstructured":"Al-Kufaidy R et al (2017) IL-17 enhances the migration of B cells during asthma by inducing CXCL13 chemokine production in structural lung cells. J Allergy Clin Immunol 139(2):696-699 e5. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.037","journal-title":"J Allergy Clin Immunol"},{"key":"9045_CR61","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/1472-6882-13-220","volume":"13","author":"RS Hang","year":"2013","unstructured":"Hang RS et al (2013) Xiao-Qing-Long-Tang shows preventive effect of asthma in an allergic asthma mouse model through neurotrophin regulation. BMC Complement Alternat Med 13:220. https:\/\/doi.org\/10.1186\/1472-6882-13-220","journal-title":"BMC Complement Alternat Med"},{"issue":"8","key":"9045_CR62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1513\/pats.200907-067DP","volume":"6","author":"DE Davies","year":"2009","unstructured":"Davies DE (2009) The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc 6(8):678\u2013682. https:\/\/doi.org\/10.1513\/pats.200907-067DP","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"9045_CR63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1165\/rcmb.2009-0304OC","volume":"44","author":"J Turner","year":"2011","unstructured":"Turner J et al (2011) Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium. Am J Respir Cell Mol Biol 44(3):276\u2013284. https:\/\/doi.org\/10.1165\/rcmb.2009-0304OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 2","key":"9045_CR64","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1513\/AnnalsATS.201711-868MG","volume":"15","author":"MA Seibold","year":"2018","unstructured":"Seibold MA (2018) Interleukin-13 stimulation reveals the cellular and functional plasticity of the airway epithelium. Ann Am Thorac Soc 15(Suppl 2):S98\u2013S102. https:\/\/doi.org\/10.1513\/AnnalsATS.201711-868MG","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"9045_CR65","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1164\/rccm.201603-0526LE","volume":"194","author":"ME Lachowicz-Scroggins","year":"2016","unstructured":"Lachowicz-Scroggins ME et al (2016) Abnormalities in MUC5AC and MUC5B protein in airway mucus in asthma. Am J Respir Crit Care Med 194(10):1296\u20131299. https:\/\/doi.org\/10.1164\/rccm.201603-0526LE","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"9045_CR66","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaci.2013.11.025","volume":"133","author":"A Poole","year":"2014","unstructured":"Poole A et al (2014) Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J Allergy Clin Immunol 133(3):670\u20138 e12. https:\/\/doi.org\/10.1016\/j.jaci.2013.11.025","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9045_CR67","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1172\/JCI84910","volume":"126","author":"LR Bonser","year":"2016","unstructured":"Bonser LR et al (2016) Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma. J Clin Invest 126(6):2367\u20132371. https:\/\/doi.org\/10.1172\/JCI84910","journal-title":"J Clin Invest"},{"issue":"10","key":"9045_CR68","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.4049\/jimmunol.162.10.6233","volume":"162","author":"K Dabbagh","year":"1999","unstructured":"Dabbagh K et al (1999) IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 162(10):6233\u20136237","journal-title":"J Immunol"},{"issue":"4","key":"9045_CR69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1165\/ajrcmb.16.4.9115759","volume":"16","author":"UA Temann","year":"1997","unstructured":"Temann UA et al (1997) A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 16(4):471\u2013478. https:\/\/doi.org\/10.1165\/ajrcmb.16.4.9115759","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"9045_CR70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1465-9921-7-39","volume":"7","author":"G Damera","year":"2006","unstructured":"Damera G, Xia B, Sachdev GP (2006) IL-4 induced MUC4 enhancement in respiratory epithelial cells in vitro is mediated through JAK-3 selective signaling. Respir Res 7(1):39. https:\/\/doi.org\/10.1186\/1465-9921-7-39","journal-title":"Respir Res"},{"issue":"1","key":"9045_CR71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/bies.10201","volume":"25","author":"KL Carraway","year":"2003","unstructured":"Carraway KL et al (2003) Cell signaling through membrane mucins. BioEssays 25(1):66\u201371. https:\/\/doi.org\/10.1002\/bies.10201","journal-title":"BioEssays"},{"issue":"1","key":"9045_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","volume":"139","author":"P Wawrzyniak","year":"2017","unstructured":"Wawrzyniak P et al (2017) Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol 139(1):93\u2013103. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.050","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9045_CR73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/alr.21077","volume":"3","author":"KA Den Beste","year":"2013","unstructured":"Den Beste KA et al (2013) Epithelial permeability alterations in an in vitro air-liquid interface model of allergic fungal rhinosinusitis. Int Forum Allergy Rhinol 3(1):19\u201325. https:\/\/doi.org\/10.1002\/alr.21077","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"9045_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2016.02.035","volume":"139","author":"K Sweerus","year":"2016","unstructured":"Sweerus K et al (2016) Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma. J Allergy Clin Immunol 139(1):1\u201310. https:\/\/doi.org\/10.1016\/j.jaci.2016.02.035","journal-title":"J Allergy Clin Immunol"},{"key":"9045_CR75","doi-asserted-by":"publisher","unstructured":"Schmidt H et al (2019) IL-13 impairs tight junctions in airway epithelia. Int J Mol Sci 20(13). https:\/\/doi.org\/10.3390\/ijms20133222","DOI":"10.3390\/ijms20133222"},{"key":"9045_CR76","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3389\/fimmu.2020.00761","volume":"11","author":"A Frey","year":"2020","unstructured":"Frey A et al (2020) More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis. Front Immunol 11:761. https:\/\/doi.org\/10.3389\/fimmu.2020.00761","journal-title":"Front Immunol"},{"issue":"2","key":"9045_CR77","doi-asserted-by":"publisher","first-page":"e24333","DOI":"10.4161\/tisb.24333","volume":"1","author":"B Saatian","year":"2013","unstructured":"Saatian B et al (2013) Interleukin-4 and interleukin-13 cause barrier dysfunction in human airway epithelial cells. Tissue Barriers 1(2):e24333. https:\/\/doi.org\/10.4161\/tisb.24333","journal-title":"Tissue Barriers"},{"issue":"8","key":"9045_CR78","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/labinvest.2012.67","volume":"92","author":"L Petecchia","year":"2012","unstructured":"Petecchia L et al (2012) Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK\/ERK1\/2-pathway. Lab Invest 92(8):1140\u20131148. https:\/\/doi.org\/10.1038\/labinvest.2012.67","journal-title":"Lab Invest"},{"issue":"6 Suppl","key":"9045_CR79","doi-asserted-by":"publisher","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286s","volume":"122","author":"SH Phan","year":"2002","unstructured":"Phan SH (2002) The myofibroblast in pulmonary fibrosis. Chest 122(6 Suppl):286S-289S. https:\/\/doi.org\/10.1378\/chest.122.6_suppl.286s","journal-title":"Chest"},{"issue":"3","key":"9045_CR80","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaci.2014.04.007","volume":"134","author":"SR Reeves","year":"2014","unstructured":"Reeves SR et al (2014) Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components. J Allergy Clin Immunol 134(3):663-670 e1. https:\/\/doi.org\/10.1016\/j.jaci.2014.04.007","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9045_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1465-9921-9-27","volume":"9","author":"NK Malavia","year":"2008","unstructured":"Malavia NK et al (2008) IL-13 induces a bronchial epithelial phenotype that is profibrotic. Respir Res 9(1):27. https:\/\/doi.org\/10.1186\/1465-9921-9-27","journal-title":"Respir Res"},{"issue":"2","key":"9045_CR82","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0002-9440(10)64563-4","volume":"157","author":"T Betsuyaku","year":"2000","unstructured":"Betsuyaku T et al (2000) Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol 157(2):525\u2013535. https:\/\/doi.org\/10.1016\/S0002-9440(10)64563-4","journal-title":"Am J Pathol"},{"issue":"2","key":"9045_CR83","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaci.2010.05.015","volume":"126","author":"SJ Wadsworth","year":"2010","unstructured":"Wadsworth SJ et al (2010) IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. J Allergy Clin Immunol 126(2):366-374 e1-8. https:\/\/doi.org\/10.1016\/j.jaci.2010.05.015","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9045_CR84","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.3892\/mmr.2018.8683","volume":"17","author":"C Huang","year":"2018","unstructured":"Huang C et al (2018) ML-7 attenuates airway inflammation and remodeling via inhibiting the secretion of Th2 cytokines in mice model of asthma. Mol Med Rep 17(5):6293\u20136300. https:\/\/doi.org\/10.3892\/mmr.2018.8683","journal-title":"Mol Med Rep"},{"issue":"8","key":"9045_CR85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/thoraxjnl-2013-204608","volume":"69","author":"D Bartis","year":"2014","unstructured":"Bartis D et al (2014) Epithelial-mesenchymal transition in lung development and disease: does it exist and is it important? Thorax 69(8):760\u2013765. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204608","journal-title":"Thorax"},{"key":"9045_CR86","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1742-2094-9-210","volume":"9","author":"X Zhou","year":"2012","unstructured":"Zhou X, Spittau B, Krieglstein K (2012) TGFbeta signalling plays an important role in IL4-induced alternative activation of microglia. J Neuroinflammation 9:210. https:\/\/doi.org\/10.1186\/1742-2094-9-210","journal-title":"J Neuroinflammation"},{"key":"9045_CR87","doi-asserted-by":"publisher","first-page":"736479","DOI":"10.3389\/fimmu.2021.736479","volume":"12","author":"H He","year":"2021","unstructured":"He H et al (2021) Sinomenine relieves airway remodeling by inhibiting epithelial-mesenchymal transition through downregulating TGF-\u03b21 and smad3 expression In Vitro and In Vivo. Front Immunol 12:736479. https:\/\/doi.org\/10.3389\/fimmu.2021.736479","journal-title":"Front Immunol"},{"issue":"6","key":"9045_CR88","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/cyto.2002.1972","volume":"19","author":"N Yuyama","year":"2002","unstructured":"Yuyama N et al (2002) Analysis of novel disease-related genes in bronchial asthma. Cytokine 19(6):287\u2013296. https:\/\/doi.org\/10.1006\/cyto.2002.1972","journal-title":"Cytokine"},{"issue":"5","key":"9045_CR89","doi-asserted-by":"publisher","first-page":"L681","DOI":"10.1152\/ajplung.00422.2009","volume":"299","author":"SR White","year":"2010","unstructured":"White SR et al (2010) Expression of IL-4\/IL-13 receptors in differentiating human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 299(5):L681\u2013L693. https:\/\/doi.org\/10.1152\/ajplung.00422.2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"9045_CR90","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.gendis.2022.10.017","volume":"10","author":"D Huang","year":"2023","unstructured":"Huang D et al (2023) The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: therapeutic implications. Genes Dis 10(4):1537\u20131551. https:\/\/doi.org\/10.1016\/j.gendis.2022.10.017","journal-title":"Genes Dis"},{"issue":"6","key":"9045_CR91","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1067\/mai.2003.1557","volume":"111","author":"J Chakir","year":"2003","unstructured":"Chakir J et al (2003) Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 111(6):1293\u20131298. https:\/\/doi.org\/10.1067\/mai.2003.1557","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9045_CR92","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/path.4808","volume":"240","author":"JK Burgess","year":"2016","unstructured":"Burgess JK et al (2016) The extracellular matrix \u2013 the under-recognized element in lung disease? J Pathol 240(4):397\u2013409. https:\/\/doi.org\/10.1002\/path.4808","journal-title":"J Pathol"},{"issue":"22","key":"9045_CR93","doi-asserted-by":"publisher","first-page":"16042","DOI":"10.3390\/ijms242216042","volume":"24","author":"IA Savin","year":"2023","unstructured":"Savin IA, Zenkova MA, Sen\u2019kova AV (2023) Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process. Int J Mol Sci 24(22):16042. https:\/\/doi.org\/10.3390\/ijms242216042","journal-title":"Int J Mol Sci"},{"issue":"21","key":"9045_CR94","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1007\/s00018-018-2899-4","volume":"75","author":"M Michalik","year":"2018","unstructured":"Michalik M et al (2018) Fibroblast-to-myofibroblast transition in bronchial asthma. Cell Mol Life Sci 75(21):3943\u20133961. https:\/\/doi.org\/10.1007\/s00018-018-2899-4","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"9045_CR95","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000073718","volume":"132","author":"A Saito","year":"2003","unstructured":"Saito A et al (2003) Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 132(2):168\u2013176. https:\/\/doi.org\/10.1159\/000073718","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"9045_CR96","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1183\/09031936.00068712","volume":"43","author":"R Firszt","year":"2014","unstructured":"Firszt R et al (2014) Interleukin-13 induces collagen type-1 expression through matrix metalloproteinase-2 and transforming growth factor-\u03b21 in airway fibroblasts in asthma. Eur Respir J 43(2):464\u2013473. https:\/\/doi.org\/10.1183\/09031936.00068712","journal-title":"Eur Respir J"},{"issue":"6","key":"9045_CR97","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.194.6.809","volume":"194","author":"CG Lee","year":"2001","unstructured":"Lee CG et al (2001) Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor b1. J Exp Med 194(6):809\u2013821. https:\/\/doi.org\/10.1084\/jem.194.6.809","journal-title":"J Exp Med"},{"issue":"1","key":"9045_CR98","doi-asserted-by":"publisher","first-page":"660","DOI":"10.4049\/jimmunol.1000471","volume":"185","author":"L Zuo","year":"2010","unstructured":"Zuo L et al (2010) IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13Ra2-inhibited pathway. J Immunol 185(1):660\u2013669. https:\/\/doi.org\/10.4049\/jimmunol.1000471","journal-title":"J Immunol"},{"issue":"6","key":"9045_CR99","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1172\/JCI5909","volume":"103","author":"Z Zhu","year":"1999","unstructured":"Zhu Z et al (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103(6):779\u2013788. https:\/\/doi.org\/10.1172\/JCI5909","journal-title":"J Clin Invest"},{"issue":"12","key":"9045_CR100","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1164\/rccm.201009-1452OC","volume":"183","author":"JL Ingram","year":"2011","unstructured":"Ingram JL et al (2011) Airway fibroblasts in asthma manifest an invasive phenotype. Am J Respir Crit Care Med 183(12):1625\u20131632. https:\/\/doi.org\/10.1164\/rccm.201009-1452OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"9045_CR101","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1165\/rcmb.2014-0290OC","volume":"54","author":"JL Ingram","year":"2016","unstructured":"Ingram JL et al (2016) Role of matrix metalloproteinases-1 and -2 in interleukin-13-suppressed elastin in airway fibroblasts in asthma. Am J Respir Cell Mol Biol 54(1):41\u201350. https:\/\/doi.org\/10.1165\/rcmb.2014-0290OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"9045_CR102","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","volume":"1832","author":"LA Borthwick","year":"2013","unstructured":"Borthwick LA, Wynn TA, Fisher AJ (2013) Cytokine mediated tissue fibrosis. Biochim Biophys Acta 1832(7):1049\u20131060. https:\/\/doi.org\/10.1016\/j.bbadis.2012.09.014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"9045_CR103","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","volume":"312","author":"JK Nguyen","year":"2020","unstructured":"Nguyen JK et al (2020) The IL-4\/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Arch Dermatol Res 312(2):81\u201392. https:\/\/doi.org\/10.1007\/s00403-019-01972-3","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"9045_CR104","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1096\/fj.03-1492fje","volume":"18","author":"JL Ingram","year":"2004","unstructured":"Ingram JL et al (2004) IL-13 and IL-1\u03b2 promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-R\u03b1. FASEB J 18(10):1132\u20131134. https:\/\/doi.org\/10.1096\/fj.03-1492fje","journal-title":"FASEB J"},{"issue":"4","key":"9045_CR105","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1172\/JCI116015","volume":"90","author":"AE Postlethwaite","year":"1992","unstructured":"Postlethwaite AE et al (1992) Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90(4):1479\u20131485. https:\/\/doi.org\/10.1172\/JCI116015","journal-title":"J Clin Invest"},{"issue":"7","key":"9045_CR106","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.4049\/jimmunol.152.7.3606","volume":"152","author":"GD Sempowski","year":"1994","unstructured":"Sempowski GD et al (1994) Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152(7):3606\u201314","journal-title":"J Immunol"},{"issue":"6","key":"9045_CR107","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/1523-1747.ep12331160","volume":"107","author":"HA Makhluf","year":"1996","unstructured":"Makhluf HA et al (1996) IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol 107(6):856\u2013859. https:\/\/doi.org\/10.1111\/1523-1747.ep12331160","journal-title":"J Invest Dermatol"},{"issue":"7","key":"9045_CR108","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/ard.56.7.426","volume":"56","author":"DL Mattey","year":"1997","unstructured":"Mattey DL et al (1997) Transforming growth factor \u03b21 and interleukin 4 induced \u03b1 smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis 56(7):426\u2013431. https:\/\/doi.org\/10.1136\/ard.56.7.426","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"9045_CR109","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/mi.2011.60","volume":"5","author":"A Bellini","year":"2012","unstructured":"Bellini A et al (2012) Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol 5(2):140\u2013149. https:\/\/doi.org\/10.1038\/mi.2011.60","journal-title":"Mucosal Immunol"},{"issue":"6","key":"9045_CR110","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1073\/pnas.052709999","volume":"99","author":"T Kodera","year":"2002","unstructured":"Kodera T et al (2002) Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-\u03b4 production by fibroblasts. Proc Natl Acad Sci U S A 99(6):3800\u20133805. https:\/\/doi.org\/10.1073\/pnas.052709999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"9045_CR111","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18(7):1028\u20131040. https:\/\/doi.org\/10.1038\/nm.2807","journal-title":"Nat Med"},{"issue":"7","key":"9045_CR112","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1096\/fj.03-1273rev","volume":"18","author":"A Leask","year":"2004","unstructured":"Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18(7):816\u2013827. https:\/\/doi.org\/10.1096\/fj.03-1273rev","journal-title":"FASEB J"},{"issue":"6","key":"9045_CR113","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol 12(6):325\u2013338. https:\/\/doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"9045_CR114","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.rmed.2011.03.020","volume":"105","author":"L Todorova","year":"2011","unstructured":"Todorova L et al (2011) TGFbeta-induced matrix production by bronchial fibroblasts in asthma: budesonide and formoterol effects. Respir Med 105(9):1296\u20131307. https:\/\/doi.org\/10.1016\/j.rmed.2011.03.020","journal-title":"Respir Med"},{"issue":"1","key":"9045_CR115","doi-asserted-by":"publisher","first-page":"20377","DOI":"10.1038\/s41598-019-56955-1","volume":"9","author":"EJ Walker","year":"2019","unstructured":"Walker EJ et al (2019) Transcriptomic changes during TGF-beta-mediated differentiation of airway fibroblasts to myofibroblasts. Sci Rep 9(1):20377. https:\/\/doi.org\/10.1038\/s41598-019-56955-1","journal-title":"Sci Rep"},{"issue":"1","key":"9045_CR116","doi-asserted-by":"publisher","first-page":"16492","DOI":"10.1038\/s41598-020-73473-7","volume":"10","author":"D Wnuk","year":"2020","unstructured":"Wnuk D et al (2020) Enhanced asthma-related fibroblast to myofibroblast transition is the result of profibrotic TGF-\u03b2\/Smad2\/3 pathway intensification and antifibrotic TGF-\u03b2\/Smad1\/5\/(8)9 pathway impairment. Sci Rep 10(1):16492. https:\/\/doi.org\/10.1038\/s41598-020-73473-7","journal-title":"Sci Rep"},{"issue":"2","key":"9045_CR117","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/hy0202.103268","volume":"39","author":"VV Petrov","year":"2002","unstructured":"Petrov VV, Fagard RH, Lijnen PJ (2002) Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39(2):258\u2013263. https:\/\/doi.org\/10.1161\/hy0202.103268","journal-title":"Hypertension"},{"issue":"4","key":"9045_CR118","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.4049\/jimmunol.170.4.2083","volume":"170","author":"FO Huaux","year":"2003","unstructured":"Huaux FO et al (2003) Dual Roles of IL-4 in Lung Injury and Fibrosis. J Immunol. 170(4):2083\u201392. https:\/\/doi.org\/10.4049\/jimmunol.170.4.2083","journal-title":"J Immunol."},{"issue":"6","key":"9045_CR119","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1067\/mai.2001.114702","volume":"107","author":"S Hashimoto","year":"2001","unstructured":"Hashimoto S et al (2001) IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway. J Allergy Clin Immunol 107(6):1001\u20131008. https:\/\/doi.org\/10.1067\/mai.2001.114702","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"9045_CR120","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1152\/japplphysiol.00950.2012","volume":"114","author":"DC Doeing","year":"2013","unstructured":"Doeing DC, Solway J (2013) Airway smooth muscle in the pathophysiology and treatment of asthma. J Appl Physiol 114(7):834\u201343. https:\/\/doi.org\/10.1152\/japplphysiol.00950.2012","journal-title":"J Appl Physiol"},{"key":"9045_CR121","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-981-13-5895-1_16","volume":"1124","author":"M Lam","year":"2019","unstructured":"Lam M, Lamanna E, Bourke JE (2019) Regulation of airway smooth muscle contraction in health and disease. Adv Exp Med Biol 1124:381\u2013422. https:\/\/doi.org\/10.1007\/978-981-13-5895-1_16","journal-title":"Adv Exp Med Biol"},{"key":"9045_CR122","unstructured":"YSC (2021) An introduction to smooth muscle mechanics. Second. Newcastle Upon Tyne: Cambridge Scholars Publishing"},{"key":"9045_CR123","doi-asserted-by":"publisher","first-page":"993406","DOI":"10.3389\/fphys.2022.993406","volume":"13","author":"DJP Xiong","year":"2022","unstructured":"Xiong DJP, Martin JG, Lauzon AM (2022) Airway smooth muscle function in asthma. Front Physiol 13:993406. https:\/\/doi.org\/10.3389\/fphys.2022.993406","journal-title":"Front Physiol"},{"issue":"6","key":"9045_CR124","doi-asserted-by":"publisher","first-page":"L958","DOI":"10.1152\/ajplung.00247.2010","volume":"300","author":"PA Risse","year":"2011","unstructured":"Risse PA et al (2011) Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotype. Lung Cell Mol Physiol 300(6):L958\u2013L966. https:\/\/doi.org\/10.1152\/ajplung.00247.2010","journal-title":"Lung Cell Mol Physiol"},{"issue":"3","key":"9045_CR125","doi-asserted-by":"publisher","first-page":"L520","DOI":"10.1152\/ajplung.00343.2001","volume":"282","author":"MM Grunstein","year":"2002","unstructured":"Grunstein MM et al (2002) IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282(3):L520\u2013L528. https:\/\/doi.org\/10.1152\/ajplung.00343.2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"9045_CR126","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1165\/rcmb.2003-0313OC","volume":"31","author":"DA Deshpande","year":"2004","unstructured":"Deshpande DA et al (2004) Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38\/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 31(1):36\u201342. https:\/\/doi.org\/10.1165\/rcmb.2003-0313OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"9045_CR127","doi-asserted-by":"publisher","first-page":"L171","DOI":"10.1152\/ajplung.00457.2007","volume":"295","author":"B Moynihan","year":"2008","unstructured":"Moynihan B et al (2008) MAP kinases mediate interleukin-13 effects on calcium signaling in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 295(1):L171\u2013L177. https:\/\/doi.org\/10.1152\/ajplung.00457.2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"9045_CR128","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jaci.2019.10.037","volume":"145","author":"ML Manson","year":"2020","unstructured":"Manson ML et al (2020) IL-13 and IL-4, but not IL-5 nor IL-17A, induce hyperresponsiveness in isolated human small airways. J Allergy Clin Immunol 145(3):808\u2013817. https:\/\/doi.org\/10.1016\/j.jaci.2019.10.037","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9045_CR129","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pupt.2009.12.005","volume":"23","author":"YD Gao","year":"2010","unstructured":"Gao YD et al (2010) Promoting effects of IL-13 on Ca2+ release and store-operated Ca2+ entry in airway smooth muscle cells. Pulm Pharmacol Ther 23(3):182\u2013189. https:\/\/doi.org\/10.1016\/j.pupt.2009.12.005","journal-title":"Pulm Pharmacol Ther"},{"issue":"5","key":"9045_CR130","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1067\/mai.2003.1451","volume":"11","author":"K Espinosa","year":"2003","unstructured":"Espinosa K et al (2003) CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 11(5):1032\u20131040. https:\/\/doi.org\/10.1067\/mai.2003.1451","journal-title":"J Allergy Clin Immunol"},{"key":"9045_CR131","doi-asserted-by":"publisher","first-page":"D258","DOI":"10.2741\/page","volume":"5","author":"K Page","year":"2000","unstructured":"Page K, Hershenson MB (2000) Mitogen-activated signaling and cell cycle regulation in airway smooth muscle. Front Biosci 5:D258\u2013D267. https:\/\/doi.org\/10.2741\/page","journal-title":"Front Biosci"},{"issue":"6","key":"9045_CR132","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.4049\/jimmunol.180.6.4191","volume":"180","author":"Y Ohta","year":"2008","unstructured":"Ohta Y et al (2008) Dual modulation of airway smooth muscle contraction by Th2 cytokines via matrix metalloproteinase-1 production. J Immunol 180(6):4191\u20134199. https:\/\/doi.org\/10.4049\/jimmunol.180.6.4191","journal-title":"J Immunol"},{"issue":"4","key":"9045_CR133","doi-asserted-by":"publisher","first-page":"L847","DOI":"10.1152\/ajplung.00245.2001","volume":"282","author":"PE Moore","year":"2002","unstructured":"Moore PE et al (2002) IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am J Physiol Lung Cell Mol Physiol 282(4):L847\u2013L853. https:\/\/doi.org\/10.1152\/ajplung.00245.2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"9045_CR134","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1165\/rcmb.2006-0172OC","volume":"37","author":"K Parameswaran","year":"2007","unstructured":"Parameswaran K et al (2007) Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. Am J Respir Cell Mol Biol 37(2):240\u2013247. https:\/\/doi.org\/10.1165\/rcmb.2006-0172OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"9045_CR135","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.4049\/jimmunol.164.11.5704","volume":"164","author":"M Mori","year":"2000","unstructured":"Mori M et al (2000) IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival. J Immunol 164(11):5704\u20135712. https:\/\/doi.org\/10.4049\/jimmunol.164.11.5704","journal-title":"J Immunol"},{"issue":"7","key":"9045_CR136","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.yexcr.2006.01.002","volume":"312","author":"JF Lafreniere","year":"2006","unstructured":"Lafreniere JF et al (2006) Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 312(7):1127\u20131141. https:\/\/doi.org\/10.1016\/j.yexcr.2006.01.002","journal-title":"Exp Cell Res"},{"issue":"5","key":"9045_CR137","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3346\/jkms.2008.23.5.857","volume":"23","author":"JY Shim","year":"2008","unstructured":"Shim JY et al (2008) The effect of interleukin-4 and amphiregulin on the proliferation of human airway smooth muscle cells and cytokine release. J Korean Med Sci 23(5):857\u2013863. https:\/\/doi.org\/10.3346\/jkms.2008.23.5.857","journal-title":"J Korean Med Sci"},{"issue":"4","key":"9045_CR138","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1164\/rccm.200509-1420OC","volume":"174","author":"V Chan","year":"2006","unstructured":"Chan V et al (2006) Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 174(4):379\u2013385. https:\/\/doi.org\/10.1164\/rccm.200509-1420OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"9045_CR139","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1465-9921-6-9","volume":"6","author":"F Syed","year":"2005","unstructured":"Syed F et al (2005) The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir Res 6(1):9. https:\/\/doi.org\/10.1186\/1465-9921-6-9","journal-title":"Respir Res"},{"issue":"1","key":"9045_CR140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","volume":"75","author":"SM McCormick","year":"2015","unstructured":"McCormick SM, Heller NM (2015) Commentary: IL-4 and IL-13 receptors and signaling. Cytokine 75(1):38\u201350. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.023","journal-title":"Cytokine"},{"key":"9045_CR141","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","volume":"9","author":"IS Junttila","year":"2018","unstructured":"Junttila IS (2018) Tuning the cytokine responses: an update on interleukin (IL)-4 and IL-13 receptor complexes. Front Immunol 9:888. https:\/\/doi.org\/10.3389\/fimmu.2018.00888","journal-title":"Front Immunol"},{"key":"9045_CR142","doi-asserted-by":"publisher","unstructured":"NM, H et al (2012) The type I and type II receptor complexes for IL-4 and IL-13 differentially regulate allergic lung inflammation. Allergic Diseases-Highlights in the Clinic, Mechanisms and Treatment. https:\/\/doi.org\/10.5772\/25650","DOI":"10.5772\/25650"},{"issue":"1","key":"9045_CR143","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","volume":"50","author":"H Harb","year":"2020","unstructured":"Harb H, Chatila TA (2020) Mechanisms of Dupilumab. Clin Exp Allergy 50(1):5\u201314. https:\/\/doi.org\/10.1111\/cea.13491","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"9045_CR144","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2012-02-408252","volume":"120","author":"D R\u00fcckerl","year":"2012","unstructured":"R\u00fcckerl D et al (2012) Induction of IL-4Ralpha-dependent microRNAs identifies PI3K\/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo. Blood 120(11):2307\u20132316. https:\/\/doi.org\/10.1182\/blood-2012-02-408252","journal-title":"Blood"},{"issue":"1","key":"9045_CR145","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nn1812","volume":"10","author":"SJ Russo","year":"2007","unstructured":"Russo SJ et al (2007) IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10(1):93\u201399. https:\/\/doi.org\/10.1038\/nn1812","journal-title":"Nat Neurosci"},{"issue":"6","key":"9045_CR146","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1128\/MCB.18.6.3395","volume":"18","author":"CH Shen","year":"1998","unstructured":"Shen CH, Stavnezer J (1998) Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription. Mol Cell Biol 18(6):3395\u20133404. https:\/\/doi.org\/10.1128\/MCB.18.6.3395","journal-title":"Mol Cell Biol"},{"issue":"12","key":"9045_CR147","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/intimm\/13.12.1479","volume":"13","author":"J Zamorano","year":"2001","unstructured":"Zamorano J et al (2001) NF-kappa B activation plays an important role in the IL-4-induced protection from apoptosis. Int Immunol 13(12):1479\u20131487. https:\/\/doi.org\/10.1093\/intimm\/13.12.1479","journal-title":"Int Immunol"},{"key":"9045_CR148","doi-asserted-by":"publisher","unstructured":"Iwaszko M, Bialy S, Bogunia-Kubik K (2021) Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells 10(11). https:\/\/doi.org\/10.3390\/cells10113000","DOI":"10.3390\/cells10113000"},{"key":"9045_CR149","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/bs.apha.2023.04.004","volume":"98","author":"N McClean","year":"2023","unstructured":"McClean N, Hasday JD, Shapiro P (2023) Progress in the development of kinase inhibitors for treating asthma and COPD. Adv Pharmacol 98:145\u2013178. https:\/\/doi.org\/10.1016\/bs.apha.2023.04.004","journal-title":"Adv Pharmacol"},{"issue":"34","key":"9045_CR150","doi-asserted-by":"publisher","first-page":"e2401251121","DOI":"10.1073\/pnas.2401251121","volume":"121","author":"U Ngo","year":"2024","unstructured":"Ngo U et al (2024) IL-13 and IL-17A activate \u03b21 integrin through an NF-kB\/Rho kinase\/PIP5K1\u03b3 pathway to enhance force transmission in airway smooth muscle. Proc Natl Acad Sci U S A 121(34):e2401251121. https:\/\/doi.org\/10.1073\/pnas.2401251121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9045_CR151","doi-asserted-by":"publisher","first-page":"e100734","DOI":"10.1371\/journal.pone.0100734","volume":"9","author":"P Reece","year":"2014","unstructured":"Reece P et al (2014) IL-4 and IL-13 differentially regulate TLR-induced eosinophil-basophil differentiation of cord blood CD34+ progenitor cells. PLoS ONE 9(6):e100734. https:\/\/doi.org\/10.1371\/journal.pone.0100734","journal-title":"PLoS ONE"},{"issue":"3","key":"9045_CR152","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2011.10.043","volume":"129","author":"Q Wu","year":"2012","unstructured":"Wu Q et al (2012) IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase. J Allergy Clin Immunol 129(3):825\u2013833. https:\/\/doi.org\/10.1016\/j.jaci.2011.10.043","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9045_CR153","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1164\/ajrccm.164.1.2008060","volume":"164","author":"JC Laporte","year":"2001","unstructured":"Laporte JC et al (2001) Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164(1):141\u2013148. https:\/\/doi.org\/10.1164\/ajrccm.164.1.2008060","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"9045_CR154","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","volume":"132","author":"SL LaPorte","year":"2008","unstructured":"LaPorte SL et al (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system. Cell 132(2):259\u2013272. https:\/\/doi.org\/10.1016\/j.cell.2007.12.030","journal-title":"Cell"},{"issue":"3","key":"9045_CR155","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.str.2010.01.003","volume":"18","author":"PJ Lupardus","year":"2001","unstructured":"Lupardus PJ, Birnbaum ME, Garcia KC (2001) Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13R\u03b12. Structure 18(3):332\u2013342. https:\/\/doi.org\/10.1016\/j.str.2010.01.003","journal-title":"Structure"},{"issue":"4","key":"9045_CR156","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1067\/mai.2003.1333","volume":"111","author":"GK Hershey","year":"2003","unstructured":"Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111(4):677\u201390. https:\/\/doi.org\/10.1067\/mai.2003.1333. (quiz 691)","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9045_CR157","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaci.2012.06.034","volume":"130","author":"JL Ingram","year":"2012","unstructured":"Ingram JL, Kraft M (2012) IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies. J Allergy Clin Immunol 130(4):829\u201342. https:\/\/doi.org\/10.1016\/j.jaci.2012.06.034. (quiz 843-4)","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"9045_CR158","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/all.13424","volume":"73","author":"J Liu","year":"2018","unstructured":"Liu J et al (2018) Role of IL-13Ralpha2 in modulating IL-13-induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa. Allergy 73(8):1673\u20131685. https:\/\/doi.org\/10.1111\/all.13424","journal-title":"Allergy"},{"issue":"1","key":"9045_CR159","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nm1332","volume":"12","author":"S Fichtner-Feigl","year":"2006","unstructured":"Fichtner-Feigl S et al (2006) IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12(1):99\u2013106. https:\/\/doi.org\/10.1038\/nm1332","journal-title":"Nat Med"},{"issue":"1","key":"9045_CR160","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2047-1440-2-16","volume":"2","author":"SM Brunner","year":"2013","unstructured":"Brunner SM et al (2013) IL-13 signaling via IL-13Ralpha2 triggers TGF-beta1-dependent allograft fibrosis. Transplant Res 2(1):16. https:\/\/doi.org\/10.1186\/2047-1440-2-16","journal-title":"Transplant Res"},{"issue":"1","key":"9045_CR161","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4049\/jimmunol.180.1.522","volume":"180","author":"T Zheng","year":"2008","unstructured":"Zheng T et al (2008) IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung. J Immunol 180(1):522\u2013529. https:\/\/doi.org\/10.4049\/jimmunol.180.1.522","journal-title":"J Immunol"},{"issue":"10","key":"9045_CR162","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1172\/JCI31546","volume":"117","author":"MS Wilson","year":"2007","unstructured":"Wilson MS et al (2007) IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 117(10):2941\u20132951. https:\/\/doi.org\/10.1172\/JCI31546","journal-title":"J Clin Invest"},{"issue":"8","key":"9045_CR163","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/resp.14520","volume":"28","author":"PA Shah","year":"2023","unstructured":"Shah PA, Brightling C (2023) Biologics for severe asthma-Which, when and why? Respirology 28(8):709\u2013721. https:\/\/doi.org\/10.1111\/resp.14520","journal-title":"Respirology"},{"issue":"4","key":"9045_CR164","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000097357","volume":"142","author":"H Nakajima","year":"2007","unstructured":"Nakajima H, Takatsu K (2007) Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 142(4):265\u2013273. https:\/\/doi.org\/10.1159\/000097357","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"9045_CR165","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2249.2002.01973.x","volume":"130","author":"TK Hart","year":"2002","unstructured":"Hart TK et al (2002) Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin Exp Immunol 130(1):93\u2013100. https:\/\/doi.org\/10.1046\/j.1365-2249.2002.01973.x","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"9045_CR166","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4161\/mabs.1.3.8352","volume":"1","author":"AA Long","year":"2009","unstructured":"Long AA (2009) Monoclonal antibodies and other biologic agents in the treatment of asthma. MAbs 1(3):237\u2013246. https:\/\/doi.org\/10.4161\/mabs.1.3.8352","journal-title":"MAbs"},{"key":"9045_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104782","volume":"158","author":"HL Tay","year":"2020","unstructured":"Tay HL, Foster PS (2020) Biologics or immunotherapeutics for asthma? Pharmacol Res 158:104782. https:\/\/doi.org\/10.1016\/j.phrs.2020.104782","journal-title":"Pharmacol Res"},{"issue":"6","key":"9045_CR168","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1164\/ajrccm.160.6.9808146","volume":"160","author":"LC Borish","year":"1999","unstructured":"Borish LC et al (1999) Interleukin-4 receptor in moderate atopic asthma. A phase I\/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 160(6):1816\u201323. https:\/\/doi.org\/10.1164\/ajrccm.160.6.9808146","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"9045_CR169","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1067\/mai.2001.115624","volume":"107","author":"LC Borish","year":"2001","unstructured":"Borish LC et al (2001) Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 107(6):963\u2013970. https:\/\/doi.org\/10.1067\/mai.2001.115624","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9045_CR170","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nm.2754","volume":"18","author":"CA Akdis","year":"2012","unstructured":"Akdis CA (2012) Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 18(5):736\u2013749. https:\/\/doi.org\/10.1038\/nm.2754","journal-title":"Nat Med"},{"issue":"2","key":"9045_CR171","doi-asserted-by":"publisher","first-page":"799","DOI":"10.4049\/jimmunol.154.2.799","volume":"154","author":"BS Bochner","year":"1995","unstructured":"Bochner BS et al (1995) IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154(2):799\u2013803","journal-title":"J Immunol"},{"issue":"9","key":"9045_CR172","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.4049\/jimmunol.149.9.2954","volume":"149","author":"DM Briscoe","year":"1992","unstructured":"Briscoe DM, Cotran RS, Pober JS (1992) Effects of tumor necrosis factor, lipopolysaccharide, and IL-4 on the expression of vascular cell adhesion molecule-1 in vivo. Correlation with CD3+ T cell infiltration. J Immunol 149(9):2954\u201360","journal-title":"J Immunol"},{"issue":"8","key":"9045_CR173","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","volume":"49","author":"RJ Keizer","year":"2010","unstructured":"Keizer RJ et al (2010) Clinical pharmacokinetics of therapeutic monoclonal antibodies. Clin Pharmacokinet 49(8):493\u2013507. https:\/\/doi.org\/10.2165\/11531280-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"9045_CR174","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bcp.12589","volume":"80","author":"F Hua","year":"2015","unstructured":"Hua F et al (2015) A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients. Br J Clin Pharmacol 80(1):101\u2013109. https:\/\/doi.org\/10.1111\/bcp.12589","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"9045_CR175","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1164\/rccm.201008-1210OC","volume":"183","author":"GM Gauvreau","year":"2011","unstructured":"Gauvreau GM et al (2011) Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med 183(8):1007\u20131014. https:\/\/doi.org\/10.1164\/rccm.201008-1210OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"9045_CR176","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.arbres.2014.02.002","volume":"50","author":"S Quirce","year":"2014","unstructured":"Quirce S et al (2014) Future biologic therapies in asthma. Arch Bronconeumol 50(8):355\u2013361. https:\/\/doi.org\/10.1016\/j.arbres.2014.02.002","journal-title":"Arch Bronconeumol"},{"issue":"8","key":"9045_CR177","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jmb.2013.01.024","volume":"425","author":"M Ultsch","year":"2013","unstructured":"Ultsch M et al (2013) Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab. J Mol Biol 425(8):1330\u20131339. https:\/\/doi.org\/10.1016\/j.jmb.2013.01.024","journal-title":"J Mol Biol"},{"issue":"12","key":"9045_CR178","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J et al (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365(12):1088\u20131098. https:\/\/doi.org\/10.1056\/NEJMoa1106469","journal-title":"N Engl J Med"},{"issue":"3","key":"9045_CR179","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jaci.2013.03.051","volume":"132","author":"M Noonan","year":"2013","unstructured":"Noonan M et al (2013) Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. J Allergy Clin Immunol 132(3):567-574 e12. https:\/\/doi.org\/10.1016\/j.jaci.2013.03.051","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9045_CR180","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/cea.12220","volume":"44","author":"H Scheerens","year":"2014","unstructured":"Scheerens H et al (2014) The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy 44(1):38\u201346. https:\/\/doi.org\/10.1111\/cea.12220","journal-title":"Clin Exp Allergy"},{"key":"9045_CR181","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/JAA.S69932","volume":"8","author":"DJ Maselli","year":"2015","unstructured":"Maselli DJ, Keyt H, Rogers L (2015) Profile of lebrikizumab and its potential in the treatment of asthma. J Asthma Allergy 8:87\u201392. https:\/\/doi.org\/10.2147\/JAA.S69932","journal-title":"J Asthma Allergy"},{"issue":"8","key":"9045_CR182","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","volume":"70","author":"NA Hanania","year":"2015","unstructured":"Hanania NA et al (2015) Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax 70(8):748\u2013756. https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206719","journal-title":"Thorax"},{"issue":"12","key":"9045_CR183","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/cea.13731","volume":"50","author":"CD Austin","year":"2020","unstructured":"Austin CD et al (2020) A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Clin Exp Allergy 50(12):1342\u20131351. https:\/\/doi.org\/10.1111\/cea.13731","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"9045_CR184","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1365-2222.2005.02299.x","volume":"35","author":"C Blanchard","year":"2005","unstructured":"Blanchard C et al (2005) Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin Exp Allergy 35(8):1096\u20131103. https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02299.x","journal-title":"Clin Exp Allergy"},{"key":"9045_CR185","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2466-10-3","volume":"10","author":"D Singh","year":"2010","unstructured":"Singh D et al (2010) A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. BMC Pulm Med 10:3. https:\/\/doi.org\/10.1186\/1471-2466-10-3","journal-title":"BMC Pulm Med"},{"issue":"2","key":"9045_CR186","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1183\/09031936.00223411","volume":"41","author":"E Piper","year":"2013","unstructured":"Piper E et al (2013) A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J 41(2):330\u2013338. https:\/\/doi.org\/10.1183\/09031936.00223411","journal-title":"Eur Respir J"},{"issue":"9","key":"9045_CR187","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S2213-2600(15)00197-6","volume":"3","author":"CE Brightling","year":"2015","unstructured":"Brightling CE et al (2015) Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 3(9):692\u2013701. https:\/\/doi.org\/10.1016\/S2213-2600(15)00197-6","journal-title":"Lancet Respir Med"},{"issue":"7","key":"9045_CR188","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-2600(18)30201-7","volume":"6","author":"RJ Russell","year":"2018","unstructured":"Russell RJ et al (2018) Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. Lancet Respir Med 6(7):499\u2013510. https:\/\/doi.org\/10.1016\/S2213-2600(18)30201-7","journal-title":"Lancet Respir Med"},{"issue":"7","key":"9045_CR189","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2213-2600(18)30184-X","volume":"6","author":"RA Panettieri Jr","year":"2018","unstructured":"Panettieri RA Jr et al (2018) Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials. Lancet Respir Med 6(7):511\u2013525. https:\/\/doi.org\/10.1016\/S2213-2600(18)30184-X","journal-title":"Lancet Respir Med"},{"issue":"1","key":"9045_CR190","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1164\/rccm.201511-2224LE","volume":"194","author":"CE Brightling","year":"2016","unstructured":"Brightling CE et al (2016) Effect of Anti-IL-13 treatment on airway dimensions in severe asthma. Am J Respir Crit Care Med 194(1):118\u2013120. https:\/\/doi.org\/10.1164\/rccm.201511-2224LE","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"9045_CR191","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1165\/rcmb.2013-0342OC","volume":"50","author":"LA Murray","year":"2014","unstructured":"Murray LA et al (2014) Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am J Respir Cell Mol Biol 50(5):985\u2013994. https:\/\/doi.org\/10.1165\/rcmb.2013-0342OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"9045_CR192","first-page":"1286","volume":"11","author":"SA Antoniu","year":"2010","unstructured":"Antoniu SA (2010) Pitrakinra, a dual IL-4\/IL-13 antagonist for the potential treatment of asthma and eczema. Curr Opin Investig Drugs 11(11):1286\u20131294","journal-title":"Curr Opin Investig Drugs"},{"issue":"2","key":"9045_CR193","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jaci.2012.03.030","volume":"130","author":"RE Slager","year":"2012","unstructured":"Slager RE et al (2012) IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor alpha antagonist. J Allergy Clin Immunol 130(2):516\u201322 e4. https:\/\/doi.org\/10.1016\/j.jaci.2012.03.030","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"9045_CR194","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel S et al (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368(26):2455\u20132466. https:\/\/doi.org\/10.1056\/NEJMoa1304048","journal-title":"N Engl J Med"},{"issue":"10039","key":"9045_CR195","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S et al (2016) Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet 388(10039):31\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(16)30307-5","journal-title":"Lancet"},{"issue":"1","key":"9045_CR196","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.anai.2018.08.005","volume":"122","author":"J Corren","year":"2019","unstructured":"Corren J et al (2019) Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma. Ann Allergy Asthma Immunol 122(1):41-49 e2. https:\/\/doi.org\/10.1016\/j.anai.2018.08.005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"26","key":"9045_CR197","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M et al (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378(26):2486\u20132496. https:\/\/doi.org\/10.1056\/NEJMoa1804092","journal-title":"N Engl J Med"},{"issue":"26","key":"9045_CR198","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF et al (2018) Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med 378(26):2475\u20132485. https:\/\/doi.org\/10.1056\/NEJMoa1804093","journal-title":"N Engl J Med"},{"issue":"24","key":"9045_CR199","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","volume":"385","author":"LB Bacharier","year":"2021","unstructured":"Bacharier LB et al (2021) Dupilumab in children with uncontrolled moderate-to-severe asthma. N Engl J Med 385(24):2230\u20132240. https:\/\/doi.org\/10.1056\/NEJMoa2106567","journal-title":"N Engl J Med"},{"key":"9045_CR200","doi-asserted-by":"publisher","unstructured":"De Prado Gomez L et al (2023) Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design. ERJ Open Res 9(2). https:\/\/doi.org\/10.1183\/23120541.00417-2022","DOI":"10.1183\/23120541.00417-2022"},{"issue":"3","key":"9045_CR201","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.alit.2024.02.002","volume":"73","author":"T Tajiri","year":"2024","unstructured":"Tajiri T et al (2024) Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: a prospective, observational study. Allergol Int 73(3):406\u2013415. https:\/\/doi.org\/10.1016\/j.alit.2024.02.002","journal-title":"Allergol Int"},{"issue":"9","key":"9045_CR202","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1164\/rccm.202306-1102LE","volume":"208","author":"S Svenningsen","year":"2023","unstructured":"Svenningsen S et al (2023) Effects of dupilumab on mucus plugging and ventilation defects in patients with moderate-to-severe asthma: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 208(9):995\u2013997. https:\/\/doi.org\/10.1164\/rccm.202306-1102LE","journal-title":"Am J Respir Crit Care Med"},{"key":"9045_CR203","doi-asserted-by":"publisher","first-page":"156091","DOI":"10.1016\/j.cyto.2022.156091","volume":"162","author":"G Scott","year":"2023","unstructured":"Scott G et al (2023) IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline. Cytokine 162:156091. https:\/\/doi.org\/10.1016\/j.cyto.2022.156091","journal-title":"Cytokine"},{"key":"9045_CR204","doi-asserted-by":"publisher","first-page":"109677","DOI":"10.1016\/j.clim.2023.109677","volume":"253","author":"F Cevikbas","year":"2023","unstructured":"Cevikbas F et al (2023) Eblasakimab, a novel IL-13 receptor alpha 1 monoclonal antibody, blocks STAT6 phosphorylation with low dose in human volunteers. Clin Immunol 253:109677. https:\/\/doi.org\/10.1016\/j.clim.2023.109677","journal-title":"Clin Immunol"},{"issue":"3","key":"9045_CR205","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jaad.2023.10.026","volume":"90","author":"KA Veverka","year":"2024","unstructured":"Veverka KA et al (2024) Safety and efficacy of eblasakimab, an interleukin 13 receptor alpha1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose study. J Am Acad Dermatol 90(3):504\u2013511. https:\/\/doi.org\/10.1016\/j.jaad.2023.10.026","journal-title":"J Am Acad Dermatol"},{"key":"9045_CR206","doi-asserted-by":"publisher","first-page":"878365","DOI":"10.3389\/fimmu.2022.878365","volume":"13","author":"KM Knudson","year":"2022","unstructured":"Knudson KM et al (2022) Recent advances in IL-13ralpha2-directed cancer immunotherapy. Front Immunol 13:878365. https:\/\/doi.org\/10.3389\/fimmu.2022.878365","journal-title":"Front Immunol"},{"issue":"5","key":"9045_CR207","doi-asserted-by":"publisher","first-page":"188802","DOI":"10.1016\/j.bbcan.2022.188802","volume":"1877","author":"M Jaen","year":"2022","unstructured":"Jaen M et al (2022) Interleukin 13 receptor alpha 2 (IL13Ralpha2): Expression, signaling pathways and therapeutic applications in cancer. Biochim Biophys Acta Rev Cancer 1877(5):188802. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188802","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09045-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09045-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09045-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:30:48Z","timestamp":1745227848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09045-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9045"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09045-2","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"19 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"44"}}